PEOPLE - Quidel makes appointment:
This article was originally published in Clinica
Quidel (San Diego, California) has appointed Kenneth Buechler as a director of the board. Dr Buechler, who has a doctorate in biochemistry, joins the firm after 20 years at fellow US diagnostics company Biosite, where he was president and chief scientific officer prior to the firm's acquisition by Inverness earlier this year. Quidel discovers, develops, manufactures and markets rapid, point-of-care diagnostic tests in the areas of infectious diseases and reproductive health.
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.